To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STX5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
419 supporting clones for gene STX5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL547250 placenta, Placenta Cot 25-normalized .a 1 to 849 1 to 809   tiling clone, fully sequenced, to resequence,   786/786
(100 %)
7 diff
(99.2 %id)
W96260 eye, retina .a 23 to 394 1 to 379   tiling clone,   377/383
(98 %)
13 diff
(96.7 %id)
AL572364 placenta, Placenta Cot 25-normalized .a 788 to 1740 953 to 1   tiling clone, fully sequenced, to resequence,   953/953
(100 %)
4 diff
(99.6 %id)
W96169 eye, retina .a 1376 to 1778 405 to 1   tiling clone,   405/405
(100 %)
2 diff
(99.6 %id)
DA871865 Prostate .b 1 to 496 2 to 497   tiling clone, capped   496/496
(100 %)
0 diff
(100 %id)
DA765779 tongue .b 12 to 589 2 to 579   capped   578/579
(99 %)
3 diff
(99.5 %id)
DA835679 placenta .b 59 to 565 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
BX380034 Placenta Cot 25-normalized .b 60 to 944 1 to 882       882/882
(100 %)
3 diff
(99.7 %id)
BM045599 carcinoma, cell line, Prostate .b 72 to 562 1 to 498       498/904
(55 %)
13 diff
(98.6 %id)
BM046754 carcinoma, cell line, Prostate .b 72 to 560 1 to 502       502/505
(99 %)
30 diff
(94.1 %id)
CN286717 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 73 to 616 1 to 544       544/544
(100 %)
3 diff
(99.5 %id)
BU152570 carcinoma, cell line, Prostate .b 74 to 824 1 to 758       758/949
(79 %)
14 diff
(98.6 %id)
BQ936549 carcinoma, cell line, Prostate .b 74 to 821 1 to 748       748/1050
(71 %)
4 diff
(99.7 %id)
BQ944616 carcinoma, cell line, Prostate .b 74 to 863 1 to 800       798/983
(81 %)
17 diff
(98.3 %id)
BQ929067 carcinoma, cell line, Prostate .b 74 to 880 1 to 812       810/933
(86 %)
10 diff
(99.0 %id)
DR156633 human embryonic stem cells differentiated toan early endodermal cell type .b 77 to 398 1 to 322       322/322
(100 %)
0 diff
(100 %id)
CF131354 Chondrosarcoma Lung Metastasis cell lines, lung .b 79 to 823 1 to 744       744/744
(100 %)
3 diff
(99.6 %id)
TI_159676443   .b 79 to 986 50 to 948       899/1024
(87 %)
23 diff
(97.8 %id)
TI_159676661   .b 84 to 783 51 to 750       700/1007
(69 %)
15 diff
(98.6 %id)
BM458312 lymph, lymphoma, cell line .b 87 to 1021 1 to 948       948/1167
(81 %)
32 diff
(97.3 %id)
BE908191 epithelioid carcinoma, Pancreas .b 99 to 606 1 to 512       512/893
(57 %)
6 diff
(99.4 %id)
CA394518 eye, RPE/choroid .b 162 to 730 1 to 569       569/569
(100 %)
0 diff
(100 %id)
CF132412 Chondrosarcoma Lung Metastasis cell lines, lung .b 179 to 586 1 to 408       408/408
(100 %)
0 diff
(100 %id)
BG254855 adenocarcinoma, cell line, Prostate .b 358 to 595 1 to 237       237/273
(86 %)
6 diff
(97.9 %id)
AU122143 mammary gland .b 374 to 1229 2 to 846   capped   845/845
(100 %)
13 diff
(98.5 %id)
BQ706514 Spleen .b 395 to 1300 9 to 918   tiling clone,   910/918
(99 %)
10 diff
(99.0 %id)
BX380033 Placenta Cot 25-normalized .b 1149 to 2095 949 to 1   tiling clone,   949/949
(100 %)
9 diff
(99.1 %id)
BE409305 choriocarcinoma, placenta .b 1482 to 2144 663 to 1     Submitted on the opposite strand 663/678
(97 %)
6 diff
(99.2 %id)
AU147803 mammary gland .b 1559 to 2108 548 to 1       548/548
(100 %)
8 diff
(98.6 %id)
DB329966 Prostate .b 1576 to 2108 534 to 1       534/534
(100 %)
9 diff
(98.4 %id)
BG476312 melanotic melanoma, skin .b 1672 to 2164 497 to 2   tiling clone, Submitted on the opposite strand 618/1059
(58 %)
14 diff
(98.7 %id)
CB155395 brain .c 1 to 628 1 to 628   tiling clone,   628/628
(100 %)
0 diff
(100 %id)
BX537426 human heart .c 3 to 1797 1 to 1795 V337I available from DKFZ,   1795/1826
(98 %)
4 diff
(99.8 %id)
BX508267   .c 4 to 744 1 to 741       741/741
(100 %)
2 diff
(99.8 %id)
NM_003164.3   .c 4 to 1797 1 to 1794 exact RefSeq,   1794/1794
(100 %)
0 diff
(100 %id)
DN995286 breast cancer, Mammary gland (cancer tissue) .c 5 to 632 1 to 628       628/628
(100 %)
7 diff
(98.9 %id)
BP227257   .c 13 to 572 1 to 560       560/560
(100 %)
6 diff
(99.0 %id)
BP215498 corpus callosum .c 16 to 595 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BI828849 brain, medulla .c 17 to 285 1 to 269       269/441
(60 %)
4 diff
(99.1 %id)
BP268667 thyroid .c 17 to 591 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BP327371 prostata .c 21 to 592 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
BP327346 prostata .c 21 to 592 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
BC012137 Kidney, renal cell adenocarcinoma .c 24 to 1796 1 to 1773 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1773/1773
(100 %)
1 diff
(100.0 %id)
DB091609 testis .c 27 to 521 2 to 498   capped   497/497
(100 %)
2 diff
(99.6 %id)
CR598903 Neuroblastoma Cot 10-normalized .c 32 to 1782 1 to 1751 exact     1751/1751
(100 %)
0 diff
(100 %id)
AL520262 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 32 to 867 1 to 835   fully sequenced,   835/835
(100 %)
0 diff
(100 %id)
BU528550 epidermoid carcinoma, cell line, lung .c 33 to 919 1 to 904       902/909
(99 %)
24 diff
(97.4 %id)
BP221496 colon .c 35 to 607 1 to 573       573/573
(100 %)
11 diff
(98.1 %id)
DB015646 esophageal, tumor tissue .c 36 to 495 2 to 465   capped   464/464
(100 %)
6 diff
(98.8 %id)
BJ993000 hepatoblastoma .c 38 to 637 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
BM750930 Ascites, stomach .c 38 to 586 1 to 549       549/549
(100 %)
3 diff
(99.5 %id)
BQ958795 carcinoma, cell line, Prostate .c 40 to 833 39 to 843       803/979
(82 %)
32 diff
(96.8 %id)
DA922126 small intestine .c 40 to 603 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
AK313497 cord Blood .c 41 to 1225 1 to 1185 exact     1185/1185
(100 %)
0 diff
(100 %id)
BP268073 thyroid .c 41 to 624 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA844209 placenta .c 41 to 600 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DB113782 thymus .c 41 to 497 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
DA070512 cerebellum .c 42 to 605 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA079765 cerebellum .c 42 to 616 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA256145 caudate nucleus .c 42 to 601 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA266434 caudate nucleus .c 42 to 591 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BP203189 coronary artery .c 42 to 625 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
DA470992   .c 42 to 614 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA538196 Kidney .c 42 to 615 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BU502466 carcinoma, cell line, Prostate .c 42 to 753 1 to 714       714/913
(78 %)
6 diff
(99.4 %id)
BU541999 carcinoma, cell line, Prostate .c 42 to 754 1 to 715       715/934
(76 %)
12 diff
(98.8 %id)
BU542356 carcinoma, cell line, Prostate .c 42 to 930 1 to 905       901/928
(97 %)
25 diff
(97.4 %id)
BU542585 carcinoma, cell line, Prostate .c 42 to 934 1 to 903       899/908
(99 %)
7 diff
(99.3 %id)
BU543886 carcinoma, cell line, Prostate .c 42 to 926 1 to 897       897/905
(99 %)
20 diff
(97.8 %id)
DA954730 Spleen .c 42 to 580 2 to 545   capped   544/544
(100 %)
4 diff
(99.3 %id)
DB002916 breast, tumor tissue .c 42 to 524 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
BM907032 brain, hippocampus .c 43 to 705 1 to 667       667/1168
(57 %)
29 diff
(97.6 %id)
DA430872 colon .c 44 to 484 2 to 444   capped   443/443
(100 %)
3 diff
(99.4 %id)
DA696632   .c 44 to 616 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA541155 lung .c 45 to 622 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA905629   .c 45 to 594 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA916040 small intestine .c 45 to 518 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
CF141615 CNCAP(3)T-225 cell line, Prostate .c 47 to 375 1 to 329       329/329
(100 %)
5 diff
(98.5 %id)
DA999524 breast, tumor tissue .c 48 to 561 8 to 522   capped   515/515
(100 %)
1 diff
(99.9 %id)
BM471824 eye, retinoblastoma .c 49 to 910 8 to 875       868/1081
(80 %)
25 diff
(97.7 %id)
BM906058 ovary (pool of 3) .c 50 to 843 11 to 810       800/1088
(73 %)
28 diff
(97.5 %id)
CF242794 Brain glioblastoma .c 51 to 842 1 to 792       792/892
(88 %)
4 diff
(99.6 %id)
BX462502 T cells (Jurkat cell line) .c 52 to 1062 1 to 1002       1002/1002
(100 %)
20 diff
(98.1 %id)
BQ432439 leiomyosarcoma, uterus .c 52 to 842 1 to 796       796/904
(88 %)
10 diff
(98.9 %id)
TI_57235021   .c 52 to 280 27 to 262       236/268
(88 %)
12 diff
(95.6 %id)
TI_154172436   .c 52 to 639 78 to 668       591/591
(100 %)
18 diff
(97.0 %id)
BM462985 melanotic melanoma, skin .c 53 to 842 1 to 793       793/1120
(70 %)
13 diff
(98.9 %id)
BQ686636 ductal carcinoma, cell line, Pancreas .c 53 to 843 1 to 791       791/946
(83 %)
0 diff
(100 %id)
BQ941477 large cell carcinoma, lung .c 53 to 640 1 to 603       601/831
(72 %)
21 diff
(97.5 %id)
CR601025 Placenta Cot 25-normalized .c 54 to 1764 1 to 1711 exact     1711/1711
(100 %)
0 diff
(100 %id)
BX338642 Placenta Cot 25-normalized .c 54 to 867 1 to 811   fully sequenced,   811/811
(100 %)
3 diff
(99.7 %id)
BI754737 brain .c 54 to 281 1 to 228       228/238
(95 %)
1 diff
(99.6 %id)
TI_57217438   .c 54 to 281 38 to 265       228/275
(82 %)
7 diff
(97.5 %id)
CB111672 Liver .c 54 to 490 1 to 437       437/437
(100 %)
2 diff
(99.6 %id)
BQ067745 brain .c 55 to 1018 1 to 970       970/1012
(95 %)
19 diff
(98.2 %id)
DA675631   .c 55 to 521 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
BI907861 leukocyte .c 56 to 280 1 to 232       232/238
(97 %)
14 diff
(94.2 %id)
BM562425 leukocyte .c 57 to 842 20 to 810       791/1120
(70 %)
16 diff
(98.6 %id)
BX416931 placenta .c 59 to 981 1 to 924       924/924
(100 %)
5 diff
(99.5 %id)
BM016917 astrocytoma grade IV, cell line, brain .c 60 to 280 1 to 221       221/415
(53 %)
1 diff
(99.8 %id)
T31170 brain .c 60 to 407 1 to 346       346/346
(100 %)
4 diff
(98.9 %id)
BQ223442 embryonal carcinoma, cell line, testis .c 61 to 594 1 to 533       533/931
(57 %)
19 diff
(98.0 %id)
AL568175 brain, fetal brain .c 62 to 916 1 to 858   fully sequenced,   857/857
(100 %)
14 diff
(98.4 %id)
BQ056165 lymph, lymphoma, cell line .c 63 to 512 12 to 461       450/1294
(34 %)
16 diff
(98.8 %id)
BQ056175 lymph, lymphoma, cell line .c 63 to 1064 18 to 1028       1011/1034
(97 %)
34 diff
(96.8 %id)
BQ706231 Spleen .c 63 to 949 1 to 893       893/922
(96 %)
18 diff
(98.1 %id)
BQ708115 Spleen .c 63 to 835 1 to 775       775/930
(83 %)
5 diff
(99.5 %id)
BQ642275 lymph, lymphoma, cell line .c 63 to 837 12 to 787       776/928
(83 %)
12 diff
(98.8 %id)
BP370122 testis .c 63 to 612 1 to 550       550/551
(99 %)
11 diff
(98.1 %id)
BP277639 Kidney .c 65 to 581 1 to 517       517/572
(90 %)
4 diff
(99.4 %id)
BP323418 Pancreas .c 66 to 647 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP306733   .c 68 to 633 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
DA139164 alzheimer cortex .c 69 to 609 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB038220 testis .c 69 to 633 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
H21702 breast .c 72 to 449 1 to 385       385/390
(98 %)
12 diff
(97.0 %id)
BP266581 thyroid .c 73 to 581 1 to 509       509/565
(90 %)
8 diff
(98.6 %id)
BQ879023 dorsal root ganglia .c 77 to 934 1 to 869       869/939
(92 %)
27 diff
(97.2 %id)
BX395691 Placenta Cot 25-normalized .c 80 to 923 1 to 844   fully sequenced,   844/844
(100 %)
6 diff
(99.3 %id)
H83290 eye, retina .c 83 to 277 1 to 195       195/195
(100 %)
3 diff
(98.5 %id)
AA112327   .c 83 to 420 1 to 344     Submitted on the opposite strand 344/420
(81 %)
13 diff
(97.0 %id)
BX375849 Neuroblastoma Cot 25-normalized .c 87 to 612 1 to 526       526/594
(88 %)
16 diff
(97.4 %id)
BE390499 endometrium, adenocarcinoma cell line, uterus .c 90 to 574 1 to 489       489/489
(100 %)
8 diff
(98.4 %id)
CR600704 T cells (Jurkat cell line) Cot10-normalized .c 91 to 1731 1 to 1641 exact     1641/1641
(100 %)
0 diff
(100 %id)
AL558297 T cells from T cell leukemia .c 91 to 969 1 to 878       878/960
(91 %)
7 diff
(99.3 %id)
T30862 blood, white blood cells .c 91 to 277 1 to 187       187/187
(100 %)
1 diff
(99.5 %id)
AA452374   .c 101 to 646 1 to 547     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 547/547
(100 %)
4 diff
(99.3 %id)
T09399   .c 102 to 528 1 to 432       432/435
(99 %)
7 diff
(98.4 %id)
CR600501 Neuroblastoma Cot 25-normalized .c 139 to 1785 1 to 1647 exact     1647/1647
(100 %)
0 diff
(100 %id)
BX366494 Neuroblastoma Cot 25-normalized .c 144 to 935 5 to 797   fully sequenced,   793/797
(99 %)
8 diff
(99.0 %id)
BQ212784 melanotic melanoma, skin .c 165 to 944 24 to 814       791/884
(89 %)
20 diff
(97.8 %id)
BQ653686 hepatocellular carcinoma, cell line, Liver .c 176 to 1028 7 to 869       863/897
(96 %)
19 diff
(97.9 %id)
BQ647635 hepatocellular carcinoma, cell line, Liver .c 177 to 1064 1 to 891       891/912
(97 %)
18 diff
(98.1 %id)
BQ650925 hepatocellular carcinoma, cell line, Liver .c 177 to 1064 1 to 890       890/913
(97 %)
20 diff
(97.9 %id)
CR606940 fetal brain .c 209 to 1228 1 to 1020       1020/1020
(100 %)
0 diff
(100 %id)
AL538209 brain, fetal brain .c 209 to 1228 1 to 1012   fully sequenced,   1012/1012
(100 %)
16 diff
(98.5 %id)
BM795583 stomach .c 256 to 832 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BY994539   .c 293 to 966 4 to 677       674/677
(99 %)
6 diff
(99.2 %id)
N88309   .c 299 to 613 1 to 315       315/386
(81 %)
6 diff
(98.5 %id)
CR590126 thymus .c 307 to 1772 1 to 1466       1466/1466
(100 %)
0 diff
(100 %id)
U26648   .c 311 to 1796 18 to 1505       1488/1507
(98 %)
8 diff
(99.5 %id)
BU174096 ductal carcinoma, cell line, Pancreas .c 312 to 1190 1 to 889       889/923
(96 %)
20 diff
(97.9 %id)
BX436722 thymus .c 315 to 974 10 to 668   fully sequenced,   659/659
(100 %)
7 diff
(99.0 %id)
TI_1948075032   .c 319 to 944 132 to 757       626/1414
(44 %)
17 diff
(98.8 %id)
TI_1948075300   .c 319 to 867 128 to 676   fully sequenced,   549/676
(81 %)
6 diff
(99.2 %id)
TI_1948075598   .c 319 to 905 128 to 714   fully sequenced,   587/714
(82 %)
6 diff
(99.2 %id)
TI_1948075869   .c 319 to 842 118 to 642       525/1490
(35 %)
22 diff
(98.6 %id)
TI_1948102592   .c 319 to 564 127 to 372       246/272
(90 %)
6 diff
(97.8 %id)
BT019646   .c 320 to 1223 1 to 904       904/906
(99 %)
3 diff
(99.7 %id)
BT019647   .c 320 to 1223 1 to 904       904/906
(99 %)
1 diff
(99.9 %id)
CV026192 mixed .c 320 to 837 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
CV028659 mixed .c 320 to 931 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BE740376 adenocarcinoma cell line, ovary .c 333 to 1173 1 to 833       833/934
(89 %)
20 diff
(97.9 %id)
CX759656 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 338 to 1047 1 to 710     Submitted on the opposite strand 710/710
(100 %)
0 diff
(100 %id)
R67195 whole brain .c 379 to 755 1 to 386       383/544
(70 %)
11 diff
(98.0 %id)
TI_57147462   .c 413 to 1356 62 to 1004       943/1009
(93 %)
32 diff
(96.9 %id)
CR617230 fetal brain .c 414 to 1786 1 to 1373   tiling clone,   1373/1373
(100 %)
0 diff
(100 %id)
AL534806 brain, fetal brain .c 414 to 867 1 to 455   fully sequenced,   455/455
(100 %)
3 diff
(99.4 %id)
CU450962 epidermis .c 417 to 1155 745 to 7     Submitted on the opposite strand 739/752
(98 %)
6 diff
(99.3 %id)
BI759970 pooled colon, kidney, stomach .c 419 to 1099 1 to 683       683/687
(99 %)
3 diff
(99.6 %id)
BM727520 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 425 to 1025 1 to 601     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 601/601
(100 %)
0 diff
(100 %id)
CN273718 embryonic stem cells, DMSO-treated H9 cellline .c 437 to 733 1 to 297       297/297
(100 %)
0 diff
(100 %id)
R17253 whole brain .c 440 to 789 1 to 359     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 359/374
(95 %)
10 diff
(97.4 %id)
BM762668 lymph node, stomach .c 440 to 1145 1 to 708       706/708
(99 %)
0 diff
(100 %id)
CU450710 epidermis .c 444 to 1155 718 to 7     Submitted on the opposite strand 712/718
(99 %)
4 diff
(99.5 %id)
AW391224 stomach .c 445 to 990 561 to 15       547/561
(97 %)
12 diff
(97.9 %id)
AW582166 stomach .c 445 to 990 561 to 15       547/561
(97 %)
12 diff
(97.9 %id)
BM548234 brain, hippocampus .c 451 to 1071 12 to 632       621/1176
(52 %)
7 diff
(99.5 %id)
BQ945345 carcinoma, cell line, Prostate .c 452 to 1273 34 to 867       833/1006
(82 %)
39 diff
(96.2 %id)
R63059 whole brain .c 460 to 577 1 to 118       118/118
(100 %)
0 diff
(100 %id)
BF838485 head_neck .c 465 to 999 535 to 1     Submitted on the opposite strand 535/546
(97 %)
5 diff
(99.1 %id)
BM563238 astrocytoma grade IV, cell line, brain .c 510 to 1226 788 to 66   AAA Submitted on the opposite strand 723/1134
(63 %)
18 diff
(98.5 %id)
BF806458 colon_ins .c 526 to 678 250 to 98     Submitted on the opposite strand 153/250
(61 %)
0 diff
(100 %id)
AL538208 brain, fetal brain .c 550 to 1202 650 to 1   fully sequenced,   650/650
(100 %)
9 diff
(98.7 %id)
BF971978 leiomyosarcoma cell line, uterus .c 567 to 1348 1 to 776       776/853
(90 %)
17 diff
(98.1 %id)
CN273715 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 586 to 1058 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
BM826547 Ascites, stomach .c 587 to 1205 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BM017794 astrocytoma grade IV, cell line, brain .c 590 to 1341 1 to 766       766/792
(96 %)
29 diff
(96.4 %id)
TI_59388370   .c 591 to 1341 100 to 864       765/791
(96 %)
28 diff
(96.5 %id)
BX360720 Placenta Cot 25-normalized .c 593 to 1768 1167 to 1       1167/1177
(99 %)
24 diff
(98.0 %id)
N29058 melanocyte .c 596 to 1066 1 to 472       472/476
(99 %)
6 diff
(98.8 %id)
BE392560 endometrium, adenocarcinoma cell line, uterus .c 596 to 1179 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AI268365 carcinoid, lung .c 611 to 830 220 to 1       220/220
(100 %)
12 diff
(94.6 %id)
BG912983 anaplastic oligodendroglioma with 1p/19qloss, brain .c 614 to 1362 1 to 750       750/751
(99 %)
7 diff
(99.1 %id)
CN273717 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 618 to 1198 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BE882020 leiomyosarcoma, uterus .c 651 to 1342 1 to 688       688/985
(69 %)
8 diff
(99.2 %id)
BF744101 breast .c 678 to 1019 344 to 4     Submitted on the opposite strand 341/344
(99 %)
2 diff
(99.5 %id)
TI_1948075033   .c 691 to 1235 657 to 110       546/1127
(48 %)
23 diff
(98.0 %id)
BM014645 breast, mammary adenocarcinoma, cell line .c 693 to 1381 24 to 712       692/739
(93 %)
14 diff
(98.2 %id)
TI_59392690   .c 693 to 1381 124 to 812   AAA   692/727
(95 %)
14 diff
(98.1 %id)
AW390920 stomach .c 697 to 990 301 to 8       294/309
(95 %)
9 diff
(97.1 %id)
BU942141 mixed (pool of 40 RNAs) .c 698 to 1206 1 to 508       508/568
(89 %)
6 diff
(99.0 %id)
AA602204   .c 713 to 1006 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
BF969094 adrenal cortex carcinoma, cell line, adrenal gland .c 715 to 1362 1 to 651       651/947
(68 %)
7 diff
(99.3 %id)
AA939256 carcinoid, lung .c 725 to 1189 468 to 1       466/468
(99 %)
25 diff
(94.7 %id)
BM796684 Ascites, stomach .c 733 to 1044 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
AI460018 brain, meningioma .c 752 to 1202 451 to 1       451/451
(100 %)
0 diff
(100 %id)
CB051928 leiomyosarcoma, soft tissue .c 752 to 1057 20 to 325       308/325
(94 %)
9 diff
(97.3 %id)
BX375848 Neuroblastoma Cot 25-normalized .c 758 to 1769 1009 to 1       1009/1013
(99 %)
14 diff
(98.7 %id)
AW351466 breast .c 768 to 1146 381 to 3       379/394
(96 %)
4 diff
(99.0 %id)
BU158716 melanotic melanoma, skin .c 771 to 1513 1 to 743       743/913
(81 %)
4 diff
(99.6 %id)
BF374848 stomach .c 778 to 915 1 to 139       139/139
(100 %)
2 diff
(98.6 %id)
AL520261 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 806 to 1782 976 to 1   fully sequenced,   976/976
(100 %)
1 diff
(99.9 %id)
AL565665 brain, fetal brain .c 806 to 1786 979 to 1   fully sequenced,   979/979
(100 %)
3 diff
(99.7 %id)
BX338641 Placenta Cot 25-normalized .c 806 to 1751 955 to 12   fully sequenced,   944/955
(98 %)
1 diff
(99.9 %id)
TI_1948075301   .c 806 to 1224 542 to 124   fully sequenced,   419/542
(77 %)
0 diff
(100 %id)
TI_1948075599   .c 875 to 1224 469 to 120   fully sequenced,   350/469
(74 %)
3 diff
(99.4 %id)
AL568174 brain, fetal brain .c 886 to 1733 854 to 8   fully sequenced,   847/854
(99 %)
0 diff
(100 %id)
BX395690 Placenta Cot 25-normalized .c 893 to 1767 873 to 1   fully sequenced,   873/873
(100 %)
2 diff
(99.8 %id)
BX345533 Neuroblastoma Cot 25-normalized .c 905 to 1785 879 to 1   fully sequenced,   879/879
(100 %)
2 diff
(99.8 %id)
BX436721 thymus .c 942 to 1772 834 to 1   fully sequenced,   834/834
(100 %)
14 diff
(98.4 %id)
BG105510 adrenal cortex carcinoma, cell line, adrenal gland .c 942 to 1357 1 to 415       415/427
(97 %)
2 diff
(99.6 %id)
TI_227713183   .c 942 to 1796 955 to 110   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 846/1004
(84 %)
14 diff
(98.7 %id)
TI_154107121   .c 943 to 1793 936 to 98   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 839/939
(89 %)
16 diff
(98.3 %id)
AW450498   .c 951 to 1187 253 to 17   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 237/257
(92 %)
4 diff
(98.5 %id)
AW450720   .c 951 to 1187 253 to 17   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 237/257
(92 %)
4 diff
(98.5 %id)
BF083373 colon .c 952 to 1225 15 to 289       275/337
(81 %)
18 diff
(94.7 %id)
BF734649 amnion_normal .c 952 to 1255 8 to 312       305/313
(97 %)
11 diff
(96.5 %id)
BQ375234 testis_normal .c 961 to 1244 1 to 284       284/284
(100 %)
4 diff
(98.6 %id)
BF083368 colon .c 962 to 1225 1 to 265       265/313
(84 %)
12 diff
(96.2 %id)
BQ292351 amnion_normal .c 968 to 1226 1 to 260       260/260
(100 %)
20 diff
(92.4 %id)
BF986190 placenta_normal .c 971 to 1188 69 to 287       219/287
(76 %)
6 diff
(98.0 %id)
TI_149291494   .c 978 to 1796 888 to 76   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 813/918
(88 %)
14 diff
(98.5 %id)
BG337371 leiomyosarcoma cell line, uterus .c 992 to 1518 1 to 525       525/525
(100 %)
21 diff
(96.0 %id)
AA639735 colon, colon tumor RER+ .c 1016 to 1797 787 to 5       783/788
(99 %)
8 diff
(99.0 %id)
EC440088 Prostate .c 1021 to 1120 100 to 1       100/100
(100 %)
0 diff
(100 %id)
EC528502 Prostate .c 1021 to 1120 100 to 1       100/100
(100 %)
0 diff
(100 %id)
BU626995 Alveolar Macrophage, lung .c 1039 to 1796 774 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 756/757
(99 %)
2 diff
(99.8 %id)
BU740755 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1064 to 1796 751 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 733/740
(99 %)
1 diff
(99.9 %id)
R41867 whole brain .c 1381 to 1796 454 to 35   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 420/420
(100 %)
7 diff
(98.4 %id)
BJ993001 hepatoblastoma .c 1386 to 1764 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
N20678 melanocyte .c 1389 to 1797 410 to 1       410/410
(100 %)
2 diff
(99.6 %id)
BX434041 placenta .c 1423 to 1782 375 to 16       360/382
(94 %)
0 diff
(100 %id)
AA452148   .c 1438 to 1796 399 to 41   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 359/359
(100 %)
0 diff
(100 %id)
BI820950 pooled brain, lung, testis .d 1 to 651 1 to 651   tiling clone,   651/651
(100 %)
0 diff
(100 %id)
TI_57197137   .d 1 to 651 32 to 682       651/682
(95 %)
6 diff
(99.2 %id)
CR603145 Placenta Cot 25-normalized .d 19 to 1586 1 to 1568   tiling clone,   1568/1568
(100 %)
0 diff
(100 %id)
BX338680 Placenta Cot 25-normalized .d 19 to 837 1 to 820   fully sequenced,   820/820
(100 %)
2 diff
(99.8 %id)
CF141931 CNCAP(3)T-225 cell line, Prostate .d 28 to 543 8 to 523       516/523
(98 %)
7 diff
(98.7 %id)
TI_154172764   .d 28 to 654 87 to 714       628/1166
(53 %)
7 diff
(99.4 %id)
TI_652739915   .d 62 to 674 631 to 19     Submitted on the opposite strand 613/642
(95 %)
9 diff
(98.6 %id)
BX338679 Placenta Cot 25-normalized .d 807 to 1569 784 to 18   fully sequenced,   767/784
(97 %)
8 diff
(99.0 %id)
BC002645 Uterus, endometrium adenocarcinoma .e 1 to 1780 5 to 1784 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1784/1784
(100 %)
0 diff
(100 %id)
TI_1948102253   .e 265 to 482 125 to 342       218/246
(88 %)
6 diff
(97.6 %id)
TI_1948102420   .e 265 to 499 128 to 362       235/261
(90 %)
6 diff
(97.8 %id)
TI_1948102751   .e 265 to 509 122 to 366       245/271
(90 %)
8 diff
(97.1 %id)
TI_1948102254   .e 814 to 1068 379 to 125       255/282
(90 %)
0 diff
(100 %id)
TI_1948102752   .e 849 to 1068 341 to 122       220/247
(89 %)
0 diff
(100 %id)
TI_1948102421   .e 872 to 1068 324 to 128       197/224
(87 %)
0 diff
(100 %id)
AK296675 cord Blood .f 1 to 991 1 to 991 exact tiling clone,   991/991
(100 %)
0 diff
(100 %id)
DC427729 cord Blood .f 3 to 553 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CR616870 Neuroblastoma Cot 25-normalized .g 1 to 1714 6 to 1719 exact tiling clone,   1719/1719
(100 %)
0 diff
(100 %id)
AL525017 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 1 to 851 6 to 856   fully sequenced,   856/856
(100 %)
1 diff
(99.9 %id)
AL562429 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 822 to 1703 893 to 11   fully sequenced,   883/893
(98 %)
19 diff
(97.9 %id)
AA278422 germinal center B cell .h 1 to 178 1 to 179   tiling clone, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 179/179
(100 %)
2 diff
(98.9 %id)
CR590111 Placenta Cot 25-normalized .h 3 to 1629 1 to 1627 exact tiling clone,   1627/1627
(100 %)
0 diff
(100 %id)
CR599366 fetal brain .h 4 to 1612 1 to 1609 exact     1609/1609
(100 %)
0 diff
(100 %id)
AA278855 germinal center B cell .h 1311 to 1667 374 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
BI761289 pooled colon, kidney, stomach .i 1 to 368 1 to 367   tiling clone,   367/403
(91 %)
3 diff
(99.3 %id)
TI_57147168   .i 1 to 368 39 to 405       367/441
(83 %)
9 diff
(98.0 %id)
BG723552 testis .i 42 to 366 1 to 325       325/629
(51 %)
7 diff
(98.9 %id)
BQ705930 Spleen .i 241 to 1085 1 to 846 E195K tiling clone,   846/959
(88 %)
11 diff
(98.9 %id)
BI599586 brain, hypothalamus .j 1 to 630 1 to 627   tiling clone,   627/627
(100 %)
12 diff
(98.1 %id)
BI601068 brain, hypothalamus .j 1 to 536 1 to 545   tiling clone,   497/547
(90 %)
18 diff
(96.8 %id)
TI_45213012   .j 3 to 630 80 to 704       625/704
(88 %)
13 diff
(98.2 %id)
TI_45214440   .j 3 to 536 126 to 668       495/670
(73 %)
21 diff
(96.9 %id)
DB495550 hypothalamus .j 6 to 506 1 to 501       501/508
(98 %)
6 diff
(98.9 %id)
DB503881 hypothalamus .j 6 to 446 1 to 442       442/442
(100 %)
11 diff
(97.6 %id)
AI831642 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .j 590 to 1313 727 to 5   tiling clone,   723/727
(99 %)
26 diff
(96.5 %id)
AW393376 stomach .j 979 to 1305 327 to 1       327/327
(100 %)
0 diff
(100 %id)
BE245650 leukopheresis .j 1083 to 1554 473 to 1   tiling clone,   473/475
(99 %)
12 diff
(97.5 %id)
BG434378 placenta .j 1351 to 1830 1 to 497   tiling clone,   497/498
(99 %)
17 diff
(96.6 %id)
AA650461 breast, normal ductal tissue .j 1357 to 1670 311 to 1   tiling clone,   311/317
(98 %)
14 diff
(95.6 %id)
AA719196 pineal gland .j 1592 to 2035 444 to 1   tiling clone,   444/444
(100 %)
4 diff
(99.1 %id)
AA702556 pineal gland .j 1629 to 2035 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
N22047 nose, olfactory epithelium .j 1845 to 2035 191 to 1   tiling clone,   191/191
(100 %)
1 diff
(99.5 %id)
TI_149272622   .j 1933 to 2563 687 to 59       629/1100
(57 %)
0 diff
(100 %id)
BU675209 lung, Primary Lung Epithelial Cells .j 1933 to 2537 622 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 604/631
(95 %)
4 diff
(99.4 %id)
CB049382 Prostate .j 1957 to 2552 599 to 4   tiling clone,   596/602
(99 %)
0 diff
(100 %id)
AA317218 retina .j 1990 to 2142 1 to 154       154/156
(98 %)
6 diff
(96.2 %id)
AW967054   .j 1991 to 2559 1 to 569   tiling clone,   569/687
(82 %)
4 diff
(99.5 %id)
AA213914.
matches multiple genes
muscle, skeletal muscle .j 1994 to 2537 542 to 1     Submitted on the opposite strand, also hits gene CMYA5 542/547
(99 %)
4 diff
(99.3 %id)
AI972525 Prostate .j 1995 to 2537 542 to 1       542/542
(100 %)
1 diff
(99.9 %id)
BX091619 colon, colon tumor, RER+ .j 2022 to 2364 1 to 343       343/343
(100 %)
2 diff
(99.5 %id)
BY800185 eye .j 2081 to 2513 1 to 433       433/433
(100 %)
0 diff
(100 %id)
AI760451 colon, colon tumor, RER+ .j 2086 to 2536 449 to 1       449/449
(100 %)
3 diff
(99.4 %id)
AW262886 brain, three pooled meningiomas .j 2182 to 2512 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BE159267 head_neck .j 2388 to 2653 1 to 278   tiling clone,   278/283
(98 %)
23 diff
(91.9 %id)
BM548576 brain, hippocampus .k 1 to 677 10 to 686 V45E G187R tiling clone,   677/1128
(60 %)
11 diff
(99.1 %id)
BP326213 prostata .l 1 to 512 2 to 512   tiling clone,   512/584
(87 %)
3 diff
(99.5 %id)
AL039943 testis .l 436 to 783 1 to 351   tiling clone,   351/351
(100 %)
3 diff
(99.2 %id)
BU146463 dorsal root ganglia .m 1 to 644 31 to 675   tiling clone,   650/1015
(64 %)
17 diff
(98.4 %id)
BF033624 adenocarcinoma, ovary .m 625 to 1246 1 to 625   tiling clone,   623/1056
(58 %)
8 diff
(99.3 %id)
BX508512   .n 1 to 628 1 to 630   tiling clone,   630/630
(100 %)
3 diff
(99.6 %id)
BF817539 colon_ins .n 407 to 836 445 to 18     Submitted on the opposite strand 428/445
(96 %)
0 diff
(100 %id)
W22584 eye, retina .n 448 to 1004 562 to 6       557/631
(88 %)
8 diff
(98.8 %id)
BX445962 brain, fetal brain .n 450 to 1378 950 to 1   tiling clone, Submitted on the opposite strand 931/1201
(77 %)
72 diff
(94.1 %id)
BX333151 Neuroblastoma Cot 25-normalized .n 452 to 1367 905 to 1   tiling clone,   905/977
(92 %)
15 diff
(98.5 %id)
BI908273 leukocyte .n 452 to 718 16 to 283       268/283
(94 %)
6 diff
(97.9 %id)
TI_57236286   .n 452 to 981 16 to 548       533/966
(55 %)
14 diff
(98.6 %id)
EL955146 eyeball .n 453 to 965 1 to 512       512/512
(100 %)
7 diff
(98.7 %id)
AL580153 T cells from T cell leukemia .n 459 to 1347 884 to 1       884/887
(99 %)
25 diff
(97.2 %id)
BM831929 stomach .n 506 to 850 1 to 345       345/345
(100 %)
0 diff
(100 %id)
BF689047 eye, normal pigmented retinal epithelium .n 511 to 1371 853 to 1       855/995
(85 %)
25 diff
(97.5 %id)
DR421831 eye, Pterygium .n 516 to 1208 1 to 693   tiling clone,   693/693
(100 %)
0 diff
(100 %id)
BM822593 stomach .n 516 to 975 1 to 454       458/454
(100 %)
9 diff
(98.1 %id)
AA370217 Prostate .n 532 to 861 1 to 330       330/330
(100 %)
0 diff
(100 %id)
BM821501 stomach .n 544 to 973 1 to 429       429/429
(100 %)
6 diff
(98.7 %id)
BF771695 epid_tumor .n 550 to 876 343 to 18     Submitted on the opposite strand 326/343
(95 %)
0 diff
(100 %id)
CA454835   .o-u 1 to 843 1 to 845 H28R Q64R tiling clone,   845/847
(99 %)
8 diff
(99.1 %id)
AW473349 serous papillary carcinoma, high grade, 2pooled tumors, uterus .o-u 127 to 415 1 to 289   tiling clone, Submitted on the opposite strand 289/289
(100 %)
1 diff
(99.7 %id)
AI806212 pooled .o-u 680 to 1061 383 to 3       381/383
(99 %)
0 diff
(100 %id)
AA628333   .o-u 694 to 1060 366 to 1   tiling clone,   366/366
(100 %)
2 diff
(99.5 %id)
AI002229 carcinoid, lung .o-u 701 to 1059 359 to 1       359/359
(100 %)
0 diff
(100 %id)
BG104674 adrenal cortex carcinoma, cell line, adrenal gland .o-u 837 to 1060 1 to 222   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 222/222
(100 %)
2 diff
(99.1 %id)
CB051156 Prostate .o-u 845 to 1059 1 to 215       215/215
(100 %)
0 diff
(100 %id)
BF002987 Prostate .o-u 863 to 1060 208 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 198/198
(100 %)
0 diff
(100 %id)
BF445788 sympathetic trunk .o-u 938 to 1290 1 to 353   tiling clone, Submitted on the opposite strand 353/353
(100 %)
1 diff
(99.8 %id)
H82618 eye, retina .o-u 1107 to 1448 1 to 342       342/345
(99 %)
5 diff
(98.6 %id)
TI_151801439   .o-u 1114 to 1751 121 to 760       640/794
(80 %)
56 diff
(93.0 %id)
CA446913 Chondrosarcoma, Left Pubic Bone .o-u 1118 to 1842 744 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 726/726
(100 %)
1 diff
(99.9 %id)
CD367516 Alveolar Macrophage, lung .o-u 1119 to 1845 745 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 727/727
(100 %)
0 diff
(100 %id)
CD616463   .o-u 1125 to 1290 1 to 166       166/187
(88 %)
1 diff
(99.5 %id)
CD616464   .o-u 1125 to 1290 182 to 18       165/182
(90 %)
0 diff
(100 %id)
R31336 placenta .o-u 1128 to 1408 1 to 285       285/288
(98 %)
10 diff
(96.6 %id)
AW008491 thymus, pooled .o-u 1130 to 1846 719 to 8       712/853
(83 %)
0 diff
(100 %id)
BM974109 lung .o-u 1133 to 1845 732 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 714/714
(100 %)
2 diff
(99.8 %id)
BG287161 bladder, transitional cell papilloma, cell line .o-u 1139 to 1426 1 to 287       287/492
(58 %)
4 diff
(99.2 %id)
BG745697 Spleen .o-u 1139 to 1820 734 to 36       699/779
(89 %)
0 diff
(100 %id)
AI201585 heart .o-u 1151 to 1846 700 to 4   tiling clone,   697/704
(99 %)
0 diff
(100 %id)
AI204072   .o-u 1152 to 1846 700 to 3       698/700
(99 %)
0 diff
(100 %id)
CA314179 Human Lung Epithelial cells, lung .o-u 1184 to 1845 680 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
BX351448 Placenta Cot 25-normalized .o-u 1187 to 1841 669 to 1       669/749
(89 %)
35 diff
(95.4 %id)
BM714789 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .o-u 1198 to 1832 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BE409085 choriocarcinoma, placenta .o-u 1207 to 1883 675 to 1   tiling clone, Submitted on the opposite strand 675/744
(90 %)
27 diff
(96.4 %id)
BE277818 melanotic melanoma, skin .o-u 1220 to 1882 666 to 1     Submitted on the opposite strand 666/711
(93 %)
22 diff
(97.0 %id)
BF681334 Prostate .o-u 1231 to 1409 1 to 179       179/179
(100 %)
0 diff
(100 %id)
CN273716 embryonic stem cells, DMSO-treated H9 cellline .o-u 1233 to 1400 1 to 168       168/168
(100 %)
0 diff
(100 %id)
R28513 placenta .o-u 1235 to 1594 1 to 364   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 364/364
(100 %)
7 diff
(98.1 %id)
BQ671841 epidermoid carcinoma, cell line, salivary gland .o-u 1240 to 1845 1 to 608       608/970
(62 %)
4 diff
(99.6 %id)
BM718158 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .o-u 1256 to 1518 1 to 263   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 263/263
(100 %)
0 diff
(100 %id)
H19945 brain .o-u 1273 to 1563 1 to 294   fully sequenced,   294/294
(100 %)
1 diff
(99.7 %id)
H22061 brain .o-u 1273 to 1708 1 to 438       438/438
(100 %)
6 diff
(98.7 %id)
H46342 brain .o-u 1273 to 1593 1 to 326   fully sequenced,   326/326
(100 %)
7 diff
(97.9 %id)
BQ446338 Knee, Osteoarthritic Cartilage .o-u 1277 to 1845 588 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 570/570
(100 %)
1 diff
(99.9 %id)
AI813459 2 pooled tumors (clear cell type), Kidney .o-u 1278 to 1846 556 to 5       552/565
(97 %)
0 diff
(100 %id)
BX372786 Neuroblastoma Cot 25-normalized .o-u 1291 to 1843 554 to 1       554/747
(74 %)
10 diff
(98.7 %id)
CN265796 embryonic stem cells, cell lines H1, H7, andH9 .o-u 1308 to 1449 12 to 153       142/153
(92 %)
6 diff
(96.1 %id)
TI_154003751   .o-u 1309 to 1845 663 to 127   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 537/539
(99 %)
0 diff
(100 %id)
CB242456 Human Lung Epithelial cells, lung .o-u 1314 to 1845 550 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 532/532
(100 %)
3 diff
(99.5 %id)
AI190503 heart .o-u 1336 to 1843 514 to 7       508/514
(98 %)
0 diff
(100 %id)
AI565631 anaplastic oligodendroglioma, brain .o-u 1345 to 1840 496 to 1       496/496
(100 %)
0 diff
(100 %id)
AI168248 pooled .o-u 1350 to 1846 502 to 6       497/502
(99 %)
0 diff
(100 %id)
BX096023 whole brain .o-u 1365 to 1845 495 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
AI598194 anaplastic oligodendroglioma, brain .o-u 1372 to 1845 499 to 26   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 474/474
(100 %)
6 diff
(98.8 %id)
AI685599 Prostate .o-u 1372 to 1846 478 to 4       475/478
(99 %)
0 diff
(100 %id)
AI761659 B-cell, chronic lymphotic leukemia .o-u 1384 to 1846 467 to 5       463/467
(99 %)
0 diff
(100 %id)
DB575128 hypothalamus .o-u 1387 to 1843 1 to 457     Submitted on the opposite strand 457/459
(99 %)
3 diff
(99.4 %id)
AI859117 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o-u 1391 to 1846 456 to 1       456/456
(100 %)
0 diff
(100 %id)
DB566607 hypothalamus .o-u 1393 to 1843 1 to 451     Submitted on the opposite strand 451/453
(99 %)
3 diff
(99.4 %id)
AW082277 pooled .o-u 1394 to 1845 468 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 452/452
(100 %)
1 diff
(99.8 %id)
AI078306 liver and spleen .o-u 1395 to 1846 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AW149402 brain, medulloblastoma .o-u 1397 to 1845 467 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 451/451
(100 %)
14 diff
(96.9 %id)
CA433470 mixed .o-u 1407 to 1845 457 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 439/439
(100 %)
0 diff
(100 %id)
AA010842 eye, retina .o-u 1410 to 1688 278 to 1       278/278
(100 %)
2 diff
(99.3 %id)
AA833752 germinal center B cell .o-u 1410 to 1774 365 to 1       365/365
(100 %)
3 diff
(99.2 %id)
CA433981 Bone, Subchondral Bone .o-u 1413 to 1845 451 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 433/433
(100 %)
7 diff
(98.4 %id)
AW075989 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .o-u 1424 to 1845 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
AI288627 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o-u 1425 to 1846 422 to 1       422/432
(97 %)
1 diff
(99.8 %id)
AI149049 placenta .o-u 1426 to 1846 426 to 7       420/428
(98 %)
0 diff
(100 %id)
AW518155 lymph node, lymphoma, follicular mixed small and largecell .o-u 1437 to 1846 410 to 1       410/415
(98 %)
0 diff
(100 %id)
AW170231 cervix .o-u 1438 to 1845 419 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 408/408
(100 %)
1 diff
(99.8 %id)
AW263153 pooled .o-u 1438 to 1846 417 to 9       409/417
(98 %)
0 diff
(100 %id)
BM987891 mixed .o-u 1439 to 1845 425 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
AV697687 hepatocellular carcinoma .o-u 1440 to 1845 1 to 406   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 406/406
(100 %)
1 diff
(99.8 %id)
AV697688 hepatocellular carcinoma .o-u 1440 to 1846 1 to 407       407/614
(66 %)
12 diff
(98.1 %id)
AV694213 hepatocellular carcinoma .o-u 1440 to 1846 1 to 407       407/410
(99 %)
1 diff
(99.8 %id)
AV694227 hepatocellular carcinoma .o-u 1440 to 1845 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
AV689122 hepatocellular carcinoma .o-u 1440 to 1845 1 to 406   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 406/406
(100 %)
0 diff
(100 %id)
AV691419 hepatocellular carcinoma .o-u 1440 to 1845 1 to 406   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 406/406
(100 %)
1 diff
(99.8 %id)
BQ023287 placenta .o-u 1440 to 1845 424 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 406/406
(100 %)
0 diff
(100 %id)
CA428709 Bone, Subchondral Bone .o-u 1446 to 1845 418 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 400/400
(100 %)
4 diff
(99.0 %id)
AW170158 cervix .o-u 1447 to 1845 410 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 399/399
(100 %)
2 diff
(99.5 %id)
AW131243 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .o-u 1448 to 1846 402 to 4       399/402
(99 %)
0 diff
(100 %id)
BQ023464 placenta .o-u 1449 to 1845 415 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 397/398
(99 %)
1 diff
(99.8 %id)
AW300846 colon, moderately differentiated adenocarcinoma .o-u 1452 to 1746 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AI167473 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o-u 1457 to 1845 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
H82619 eye, retina .o-u 1458 to 1835 378 to 1       378/378
(100 %)
0 diff
(100 %id)
R60004 whole brain .o-u 1462 to 1845 398 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 385/385
(100 %)
1 diff
(99.8 %id)
AI351687   .o-u 1465 to 1846 384 to 3       382/384
(99 %)
0 diff
(100 %id)
AA568321   .o-u 1473 to 1774 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AW511291 pooled .o-u 1478 to 1846 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
AI149099 uterus .o-u 1483 to 1845 378 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 363/363
(100 %)
1 diff
(99.8 %id)
H38414 brain .o-u 1484 to 1846 368 to 6       363/368
(98 %)
0 diff
(100 %id)
BU741794 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .o-u 1488 to 1845 377 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 359/359
(100 %)
3 diff
(99.2 %id)
AA582295 Kidney, kidney tumor .o-u 1497 to 1769 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
BU753300 placenta .o-u 1506 to 1845 359 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 342/342
(100 %)
4 diff
(98.9 %id)
AI609977 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .o-u 1510 to 1747 11 to 248     Submitted on the opposite strand 238/248
(95 %)
6 diff
(97.6 %id)
AA628988   .o-u 1514 to 1840 333 to 7       327/333
(98 %)
0 diff
(100 %id)
AI054389 ovary, papillary serous carcinoma .o-u 1520 to 1774 255 to 1       255/276
(92 %)
1 diff
(99.7 %id)
AI349138 bronchioalveolar carcinoma, lung .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AI345869 bronchioalveolar carcinoma, lung .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AI345859 bronchioalveolar carcinoma, lung .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AI344094 bronchioalveolar carcinoma, lung .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AI609961 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .o-u 1520 to 1747 36 to 263     Submitted on the opposite strand 228/263
(86 %)
6 diff
(97.8 %id)
AW071344 bone marrow, stem cell 34+/38+ .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AW075139 bone marrow, stem cell 34+/38+ .o-u 1520 to 1747 13 to 240     Submitted on the opposite strand 228/240
(95 %)
6 diff
(97.5 %id)
AW075195 bone marrow, stem cell 34+/38+ .o-u 1520 to 1747 39 to 266     Submitted on the opposite strand 228/266
(85 %)
6 diff
(97.8 %id)
AW268276 invasive adenocarcinoma, lung .o-u 1520 to 1747 24 to 251     Submitted on the opposite strand 228/251
(90 %)
6 diff
(97.7 %id)
AW268930 invasive adenocarcinoma, lung .o-u 1520 to 1747 51 to 278     Submitted on the opposite strand 228/278
(82 %)
6 diff
(97.9 %id)
AW274210 invasive adenocarcinoma, lung .o-u 1520 to 1747 45 to 272     Submitted on the opposite strand 228/272
(83 %)
6 diff
(97.8 %id)
BF718557 epidermis, skin .o-u 1526 to 1843 320 to 3       318/320
(99 %)
0 diff
(100 %id)
AI193960 lung .o-u 1528 to 1844 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
AI761660 B-cell, chronic lymphotic leukemia .o-u 1531 to 1845 322 to 6       317/322
(98 %)
0 diff
(100 %id)
AW002205 thymus, pooled .o-u 1531 to 1845 338 to 24   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 315/315
(100 %)
7 diff
(97.8 %id)
AW071232 colon, colonic mucosa from 3 patients with Crohn'sdisease .o-u 1531 to 1845 330 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
H19946 brain .o-u 1533 to 1845 320 to 1   fully sequenced,   320/320
(100 %)
2 diff
(99.4 %id)
T15805   .o-u 1534 to 1845 315 to 1       315/395
(79 %)
5 diff
(98.8 %id)
AI266026 lung .o-u 1536 to 1846 312 to 1       312/312
(100 %)
3 diff
(99.1 %id)
AI422502 brain, glioblastoma (pooled) .o-u 1536 to 1845 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
AI471368 colon, moderately-differentiated adenocarcinoma .o-u 1536 to 1845 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
H46271 brain .o-u 1563 to 1828 267 to 1   fully sequenced,   267/267
(100 %)
2 diff
(99.3 %id)
R28661 placenta .o-u 1564 to 1845 297 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 284/284
(100 %)
7 diff
(97.6 %id)
AA907437 carcinoid, lung .o-u 1573 to 1845 291 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
BM714213 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .o-u 1573 to 1845 10 to 282   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 273/282
(96 %)
6 diff
(97.9 %id)
AI969100 brain, four pooled pituitary adenomas .o-u 1586 to 1845 278 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 260/260
(100 %)
4 diff
(98.5 %id)
BP389702 pancreatic islet .o-u 1590 to 1846 1 to 257     Submitted on the opposite strand 257/262
(98 %)
1 diff
(99.7 %id)
AA579409   .o-u 1600 to 1774 175 to 1       175/181
(96 %)
0 diff
(100 %id)
BM676589 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .o-u 1609 to 1845 255 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 237/237
(100 %)
0 diff
(100 %id)
T35206 prostate gland .o-u 1618 to 1845 228 to 1       228/230
(99 %)
0 diff
(100 %id)
AI620964 Prostate .o-u 1621 to 1845 239 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
BM718661 eye, fetal eye .o-u 1626 to 1845 1 to 220   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
AA583721 larynx .o-u 1635 to 1815 181 to 1       181/181
(100 %)
0 diff
(100 %id)
AW007938 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .o-u 1664 to 1845 218 to 37   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 182/182
(100 %)
12 diff
(93.5 %id)
EC473910 Prostate .o-u 1696 to 1797 1 to 95       95/95
(100 %)
6 diff
(93.7 %id)
EC577624 Prostate .o-u 1718 to 1803 1 to 87       87/87
(100 %)
1 diff
(98.9 %id)
BG460496   .p-u 1 to 581 113 to 707   tiling clone,   595/724
(82 %)
36 diff
(95.1 %id)
AA378560 synovial membrane .p-u 146 to 460 1 to 319   tiling clone,   319/319
(100 %)
4 diff
(98.8 %id)
DW437832 Liver .p-u 246 to 483 10 to 247   tiling clone,   238/247
(96 %)
6 diff
(97.6 %id)
AW385562 leiomios .p-u 359 to 661 305 to 3 L15A T16D L17P K18E K19E ... tiling clone,   303/308
(98 %)
0 diff
(100 %id)
AW393363 stomach .p-u 374 to 869 525 to 30 W7* tiling clone,   496/529
(93 %)
0 diff
(100 %id)
DB179719 kidney, tumor tissue .q 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
6 diff
(99.0 %id)
DA929793 small intestine .r-u 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
AV685400 hepatocellular carcinoma Gene STX5, variant not shown         Suspected internal deletion, this clone was ignored    
AV735561 cord Blood Gene STX5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM676013 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX5, variant not shown       AAA This clone was ignored    
BM712492 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene STX5, variant not shown         This clone was ignored    
AA369761 Prostate Gene STX5, variant not shown         This clone was ignored    
AA349107 adrenal gland Gene STX5, variant not shown              
BP326548 prostata Gene STX5, variant not shown         Suspected internal deletion, this clone was ignored    
AA425678   Gene STX5, variant not shown              
AA428466   Gene STX5, variant not shown              
AA447943   Gene STX5, variant not shown              
AA448878   Gene STX5, variant not shown              
BF344983 brain, glioblastoma with EGFR amplification Gene STX5, variant not shown         This clone was ignored    
BG547468 lung Gene STX5, variant not shown         Suspected internal deletion, this clone was ignored    
BM551142 duodenal adenocarcinoma, cell line, small intestine Gene STX5, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u, .q, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI